Methodological issues in the biological monitoring of urinary benzene and S-phenylmercapturic acid at low exposure levels

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 27, 2010, Pages 2534-2540

  Fustinoni, Silvia ^a   Campo, Laura ^a   Mercadante, Rosa ^a   Manini, Paola ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Low benzene exposure; Quality control; Urinary benzene; Urinary S phenylmercapturic acid

Indexed keywords

BIOLOGICAL MONITORING; CERTIFIED REFERENCE MATERIALS; CONCENTRATION DETERMINATION; CONCENTRATION RANGES; CONFIDENCE INTERVAL; CONTROL CHARTS; DATA PAIRS; EXPOSURE LEVEL; GASOLINE STATIONS; GOOD STABILITY; INTERNAL QUALITY; LC/MS/MS; LIMIT OF QUANTIFICATIONS; LINEAR CALIBRATION CURVE; LOW BENZENE EXPOSURE; LOW-LEVEL EXPOSURE; QUALITY OF RESULTS; QUANTIFICATION LIMIT; R VALUE; S-PHENYLMERCAPTURIC ACID; SPOT SAMPLES; URBAN POPULATION; URINARY BENZENE;

ACIDS; BENZENE; BIOLOGICAL MATERIALS; CONCENTRATION (PROCESS); MONITORING; QUALITY ASSURANCE; SLOPE STABILITY;

QUALITY CONTROL;

ACETYLCYSTEINE DERIVATIVE; BENZENE; GASOLINE; N ACETYL S PHENYLCYSTEINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOLOGICAL MONITORING; CALIBRATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PETROCHEMICAL INDUSTRY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; URBAN AREA; URINALYSIS; WORKER;

ACETYLCYSTEINE; BENZENE; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS;

EID: 77956872495     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.11.045     Document Type: Article

References (19)

1. International Agency for Research on Cancer (IARC) Monograph of carcinogenic risks in human. Overall evaluations of carcinogenicity: an updating of IARC Monographs, vol. 42 1987, International Agency for Research on Cancer (IARC), Lyon (France), p. 120.
2. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., Rappaport S.M., Shen M., Alter B.P., Wu Y., Kopp W., Waidyanatha S., Rabkin C., Guo W., Chanock S., Hayes R.B., Linet M., Kim S., Yin S., Rothman N., Smith M.T. Science 2004, 306:1774.
3. Fustinoni S., Consonni D., Campo L., Buratti M., Colombi A., Pesatori A.C., Bonzini M., Bertazzi P.A., Foà V., Garte S., Farmer P.B., Levy L.S., Pala M., Valerio F., Fontana V., Desideri A., Merlo D.F. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2237.
4. Manini P., De Palma G., Andreoli R., Poli D., Petyx M., Corradi M., Mutti A., Apostoli P. Toxicol. Lett. 2008, 181:25.
5. Hoet P., De Smedt E., Ferrari M., Imbriani M., Maestri L., Negri S., De Wilde P., Lison D., Haufroid V. Int. Arch. Occup. Environ. Health 2009, 82:985.
6. Miller J.N., Miller J.C. Statistics and Chemometrics for Analytical Chemistry 2005, Pearson Education Ltd., Essex, UK. 5th ed.
7. Schaller K.H., Angerer J., Drexler H. J. Chromatogr. B 2002, 778:403.
8. Fustinoni S., Mercadante R., Campo L. Int. Arch. Occup. Environ. Health 2009, 82:703.
9. Fustinoni S., Giampiccolo R., Pulvirenti S., Buratti M., Colombi A. J. Chromatogr. B 1999, 723:105.
10. Melikian A.A., O'Connor R., Prahalad A.K., Hu P., Li H., Kagan M., Thompson S. Carcinogenesis 1999, 20:719.
11. Mullins E. Analyst 1994, 119:369.
12. Mullins E. Analyst 1999, 124:433.
13. U.S. Food and Drug Administration (FDA), Guidance for Industry, Bioanalytical Method Validation (2001) U.S. Available on line at (last accessed 31.08.09). http://www.fda.gov/cder/guidance/4252fnl.pdf.
14. Rappaport S.M. Ann. Occup. Hyg. 1991, 35:61.
15. Schettgen T., Musiol A., Alt A., Kraus T. J. Chromatogr. B 2008, 863:283.
16. Li Y., Li A.C., Shi H., Junga H., Jiang X., Naidong W., Lauterbach J.H. Biomed. Chromatogr. 2006, 20:597.
17. Pigi E., Pigini D., Cialdella M., Faranda P., Tanfo G. Biomarkers 2007, 12:111.
18. Sterz K., Kohler D., Schettgen T., Scherer G. J. Chromatogr. B 2010, 878:2502.
19. Westgard J.O., Barry P.L., Hunt M.R. Clin. Chem. 1981, 27:493.